Modulation of cell fates and activities by phthalazinediones
Patent Number: 7,326,690
Date of First Priority Issue: Wednesday October 30th, 2002
Date Issued: Tuesday February 5th, 2008
Assignee: Bach Pharma, Inc. (North Andover, MA)
Inventors: Henry; Mark O. (North Andover, MA), Lynn; William S. (Hillsborough, NC)
From Class: Differentiation
Comments: No comments
This patent covers a pharmaceutical agent, and numerous derivatives thereof, for manipulation of cellular and stem cell activity. The family of compounds covered are called phthalazinediones, and they have previously been described to possess various anti-inflammatory activities.
The patent claims include methods of treatment for metabolic diseases and methods of decreasing metabolic stress.
View this patent on the USPTO website.
Added to StemCellPatents.com on Sunday February 10th, 2008
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.